Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Gains from Investment Securities (2021 - 2025)

Tenon Medical (TNON) has 4 years of Gains from Investment Securities data on record, last reported at $77150.0 in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 412.32% year-over-year to $77150.0; the TTM value through Sep 2025 reached $77150.0, up 412.32%, while the annual FY2024 figure was $11322.0, 1107.04% up from the prior year.
  • Gains from Investment Securities reached $77150.0 in Q3 2025 per TNON's latest filing, up from $2625.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $77150.0 in Q3 2025 and bottomed at -$1000.0 in Q4 2021.
  • Average Gains from Investment Securities over 4 years is $23200.5, with a median of $10948.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: soared 1107.04% in 2024, then plummeted 96.38% in 2025.
  • A 4-year view of Gains from Investment Securities shows it stood at -$1000.0 in 2021, then soared by 193.8% to $938.0 in 2023, then skyrocketed by 1107.04% to $11322.0 in 2024, then surged by 581.42% to $77150.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $77150.0 in Q3 2025, $2625.0 in Q2 2025, and $625.0 in Q1 2025.